Atlas Protocol

Compound plot

Trestolone structural timing shape

The page preserves the non-ester-specific registry identity instead of inventing a formulation Atlas has not modeled.

Atlas does not infer a trestolone formulation, measured concentration, outcome, or appropriate protocol from this shape.

Free · no sign-in · legacy unreviewed half-life basis · inputs remain editable

Loaded inputs

Trestolone5 mg/week · e2d

Administration-window schematic · not model output

What this page models

A minimum non-zero registry-step trestolone input across six administration weeks on an eight-week horizon.

What stays uncertain

Atlas does not infer a trestolone formulation, measured concentration, outcome, or appropriate protocol from this shape.

Why this curve?

This link explicitly selects Atlas's generic structural timing basis. Atlas combines each selected compound descriptor with the entered dose unit, cadence, administration window, and plot horizon. The live plot reports a normalized, unitless timing shape and exposes the selected basis and evidence status beside the result.

Changed inputs recompute the curve. A changed shape is a model response to changed inputs. It is not a measured concentration or an individual outcome.